V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240014259 | 240008407 | 1.56 | 86.2 | Adjuvant (A) | null | 2013-08-28 | Brentuximab | 02 | N | 240034787 | BRENTUXIMAB |
| 240014260 | 240014413 | 1.78 | null | Palliative (P) | 2016-05-11 | 2016-05-25 | R IVAC | N | null | 240034795 | GDP |
| 240014261 | 240008409 | 1.61 | 71.1 | Curative (C) | 2018-05-18 | 2018-06-25 | Brentuximab | N | N | 240034832 | BRENTUXIMAB |
| 240014262 | 240008409 | 1.71 | null | Disease modification (D) | 2014-05-26 | 2014-11-03 | BENDAMUSTINE | N | null | 240034832 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 240014263 | 240008410 | 1.55 | 77.1 | Palliative (P) | 2017-04-21 | 2017-11-11 | TRASTUZUMAB | N | N | 240034842 | HYDROXYCARBAMIDE |
| 240014264 | 240008412 | 1.71 | null | Palliative (P) | 2014-01-27 | 2014-02-07 | BEAM | 02 | N | 240034846 | METHOTREXATE |
| 240014265 | 240008413 | 1.52 | 75.9 | Disease modification (D) | 2010-11-04 | 2014-09-08 | CHLORAMBUCIL + RITUXIMAB | null | Y | 240034860 | CHLORAMBUCIL + RITUXIMAB |
| 240014266 | 240008414 | 1.71 | 81.9 | Palliative (P) | null | 2017-07-14 | DA 3 + 10 | N | N | 240034865 | CYCLOPHOSPHAMIDE |
| 240014267 | 240015386 | 1.53 | 65.3 | Curative (C) | 2015-09-14 | 2016-02-08 | R IVAC | N | N | 240034902 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 240014268 | 240008417 | 1.62 | null | Not known (9) | 2016-05-09 | 2016-12-28 | Bortezomib +/- Dexamethasone | 02 | N | 240034903 | GEMCARBO |
| 240014269 | 240008418 | 1.75 | 83 | Curative (C) | 2017-07-28 | 2017-08-03 | Carboplatin + Etoposide iv&po | 02 | N | 240034912 | CARBOPLATIN + ETOPOSIDE |
| 240014270 | 240008420 | 1.69 | 61 | null | 2016-11-10 | 2016-11-10 | Brentuximab Vedotin | 02 | N | 240034917 | BRENTUXIMAB |
| 240014271 | 240008425 | 1.8 | 92 | Curative (C) | 2015-08-09 | 2016-03-15 | Cyclophosphamide High Dose | N | N | 240034935 | LENALIDOMIDE |
| 240014272 | 240008428 | 1.62 | 79.4 | Palliative (P) | 2018-02-05 | 2018-02-13 | CHLORAMBUCIL + RITUXIMAB | 02 | N | 240034998 | CHLORAMBUCIL + RITUXIMAB |
| 240014273 | 240008430 | 1.77 | null | Palliative (P) | 2015-09-23 | 2015-12-31 | Cyclophosphamide High Dose | 2 | N | 240035005 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 240014274 | 240008431 | 1.63 | 63 | Curative (C) | 2015-06-15 | 2015-06-19 | Brentuximab | N | n | 240035013 | BRENTUXIMAB |
| 240014275 | 240008432 | 1.77 | 97 | Not known (9) | 2015-03-28 | 2015-03-28 | Brentuximab | N | N | 240035016 | BRENTUXIMAB |
| 240014276 | 240014421 | 1.71 | 80.1 | Palliative (P) | 2015-11-27 | 2015-11-29 | Chlorambucil | 02 | N | 240035043 | CHLORAMBUCIL |
| 240014277 | 240008437 | 1.7 | 80 | Palliative (P) | 2014-07-13 | 2014-07-13 | BEAM | 02 | N | 240035062 | DA |
| 240014278 | 240008439 | 1.66 | 67.1 | Curative (C) | 2015-01-01 | 2015-01-07 | FLAG + Idarubicin | N | null | 240035063 | HYDROXYCARBAMIDE |
| 240014279 | 240008440 | null | 89.6 | Palliative (P) | 2016-07-25 | 2016-08-03 | Methotrexate High Dose (3g/m2) | null | null | 240035072 | CYTARABINE |
| 240014280 | 240008441 | 1.5 | 73.2 | Curative (C) | 2016-06-22 | 2016-06-23 | LENALIDOMIDE | N | N | 240035086 | METHOTREXATE HIGH DOSE |
| 240014281 | 240008442 | 1.65 | 76 | Palliative (P) | 2015-03-25 | 2015-03-25 | Methotrexate High Dose (3g/m2) | N | N | 240035099 | CYCLOPHOSPHAMIDE |
| 240014282 | 240008444 | 1.56 | null | Curative (C) | 2013-01-08 | 2013-10-27 | Methotrexate High Dose (3g/m2) | 02 | N | 240035100 | TRASTUZUMAB |
| 240014283 | 240012514 | 1.63 | null | Palliative (P) | 2015-03-17 | 2015-12-24 | TRASTUZUMAB | N | N | 240035106 | BEAM |
| 240014284 | 240008449 | 1.77 | 91 | Palliative (P) | 2009-12-06 | 2013-12-24 | METHOTREXATE | 02 | N | 240035134 | DA |
| 240014285 | 240008450 | 1.78 | null | Disease modification (D) | 2014-12-05 | 2014-12-10 | GDP | 02 | N | 240035134 | LENALIDOMIDE |
| 240014286 | 240012519 | 1.56 | 47.9 | Palliative (P) | 2019-04-16 | 2019-04-17 | ABVD | N | N | 240035220 | LENALIDOMIDE |
| 240014287 | 240008453 | null | 56.6 | Palliative (P) | 2017-10-05 | 2017-10-05 | BEAM | 2 | N | 240035227 | METHOTREXATE HIGH DOSE |
| 240014288 | 240008454 | 1.57 | 83.4 | Curative (C) | null | 2015-06-24 | METHOTREXATE | N | null | 240035235 | LENALIDOMIDE |
| 240014289 | 240008458 | 1.45 | 75 | Palliative (P) | null | 2014-12-31 | CYCLOPHOSPHAMIDE | N | N | 240035264 | HYDROXYCARBAMIDE |
| 240014290 | 240012522 | 1.6 | 83.4 | Curative (C) | null | 2015-05-26 | LENALIDOMIDE | N | N | 240035292 | BENDAMUSTINE |
| 240014291 | 240014432 | 1.65 | 43.6 | null | 2014-10-22 | 2014-11-10 | Bortezomib (weekly) | 02 | N | 240035295 | METHOTREXATE |
| 240014292 | 240014432 | 1.45 | null | Palliative (P) | 2014-07-17 | 2014-07-17 | Brentuximab | 02 | N | 240035295 | BRENTUXIMAB |
| 240014293 | 240008462 | null | 82.2 | Curative (C) | 2017-01-22 | 2017-01-26 | IBRUTINIB | N | N | 240035303 | CARBOPLATIN + ETOPOSIDE |
| 240014294 | 240008464 | 1.61 | 63 | Not known (9) | 2013-06-23 | 2013-08-01 | CARBOPLATIN + ETOPOSIDE | N | N | 240035304 | CISPLATIN + ETOPOSIDE |
| 240014295 | 240008465 | null | 80 | Curative (C) | 2013-06-06 | 2013-06-06 | GDP | N | null | 240035318 | TRASTUZUMAB |
| 240014296 | 240008469 | 1.61 | 83.4 | Disease modification (D) | null | 2017-09-25 | CARBOPLATIN + ETOPOSIDE | 02 | N | 240035319 | METHOTREXATE |
| 240014297 | 240008475 | 1.56 | null | Curative (C) | 2018-03-21 | 2018-03-25 | Brentuximab Vedotin | 2 | N | 240035322 | BRENTUXIMAB |
| 240014298 | 240008476 | 1.53 | 61 | Curative (C) | 2016-04-27 | 2016-04-30 | IBRUTINIB | 2 | null | 240035325 | ABVD |
| 240014299 | 240008479 | 1.75 | null | Curative (C) | 2015-03-07 | 2015-03-25 | CYCLOPHOSPHAMIDE | 2 | null | 240035341 | GDP |
| 240014300 | 240012531 | 1.63 | 124.4 | null | 2019-03-05 | 2019-03-11 | Bortezomib +/- Dexamethasone | 02 | N | 240035348 | BEAM |
| 240014301 | 240008483 | 1.59 | 47.9 | Curative (C) | null | 2014-12-18 | TRASTUZUMAB | N | N | 240035356 | BEAM |
| 240014302 | 240015888 | 1.68 | 97.7 | Adjuvant (A) | null | 2014-05-05 | Cisplatin + Topotecan | null | null | 240035358 | TRASTUZUMAB |
| 240014303 | 240008485 | null | 96.5 | Curative (C) | 2013-12-26 | 2014-02-14 | CARBOPLATIN + ETOPOSIDE | N | N | 240035365 | IBRUTINIB |
| 240014304 | 240008487 | 1.6 | 72 | Not known (9) | 2019-01-06 | 2019-01-07 | Brentuximab | 02 | N | 240035371 | BRENTUXIMAB |
| 240014305 | 240008490 | null | null | Curative (C) | 2013-09-23 | 2013-09-23 | Cisplatin + Topotecan | null | null | 240035436 | FLAG + IDARUBICIN |
| 240014306 | 240008492 | 1.61 | null | null | 2015-01-12 | 2015-06-22 | DA 3+8 | N | N | 240035442 | TRASTUZUMAB |
| 240014307 | 240012540 | 1.65 | 61.5 | Disease modification (D) | 2017-02-22 | 2017-02-24 | Methotrexate High Dose (3g/m2) | N | N | 240035449 | CISPLATIN + TOPOTECAN |
| 240014308 | 240008494 | 1.76 | 101.6 | Neo-adjuvant (N) | 2017-02-19 | 2017-10-22 | GEMCITABINE | N | N | 240035451 | CARBOPLATIN + ETOPOSIDE |